1. Home
  2. ITOS vs SNDL Comparison

ITOS vs SNDL Comparison

Compare ITOS & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • SNDL
  • Stock Information
  • Founded
  • ITOS 2011
  • SNDL 2006
  • Country
  • ITOS United States
  • SNDL Canada
  • Employees
  • ITOS N/A
  • SNDL N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • SNDL Pharmaceuticals and Biotechnology
  • Sector
  • ITOS Health Care
  • SNDL Health Care
  • Exchange
  • ITOS Nasdaq
  • SNDL Nasdaq
  • Market Cap
  • ITOS 381.2M
  • SNDL 319.0M
  • IPO Year
  • ITOS 2020
  • SNDL 2019
  • Fundamental
  • Price
  • ITOS $10.18
  • SNDL $1.27
  • Analyst Decision
  • ITOS Hold
  • SNDL Buy
  • Analyst Count
  • ITOS 6
  • SNDL 1
  • Target Price
  • ITOS $10.60
  • SNDL $3.25
  • AVG Volume (30 Days)
  • ITOS 911.6K
  • SNDL 1.5M
  • Earning Date
  • ITOS 08-07-2025
  • SNDL 07-31-2025
  • Dividend Yield
  • ITOS N/A
  • SNDL N/A
  • EPS Growth
  • ITOS N/A
  • SNDL N/A
  • EPS
  • ITOS N/A
  • SNDL N/A
  • Revenue
  • ITOS $35,000,000.00
  • SNDL $645,362,646.00
  • Revenue This Year
  • ITOS N/A
  • SNDL $4.70
  • Revenue Next Year
  • ITOS N/A
  • SNDL $3.87
  • P/E Ratio
  • ITOS N/A
  • SNDL N/A
  • Revenue Growth
  • ITOS 177.89
  • SNDL 1.30
  • 52 Week Low
  • ITOS $4.80
  • SNDL $1.15
  • 52 Week High
  • ITOS $18.13
  • SNDL $2.40
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 67.57
  • SNDL 48.92
  • Support Level
  • ITOS $9.95
  • SNDL $1.15
  • Resistance Level
  • ITOS $10.20
  • SNDL $1.27
  • Average True Range (ATR)
  • ITOS 0.15
  • SNDL 0.05
  • MACD
  • ITOS -0.09
  • SNDL 0.00
  • Stochastic Oscillator
  • ITOS 90.00
  • SNDL 60.00

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About SNDL SNDL Inc.

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

Share on Social Networks: